These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9876819)

  • 1. Buspirone use for smoking cessation.
    Farid P; Abate MA
    Ann Pharmacother; 1998 Dec; 32(12):1362-4. PubMed ID: 9876819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial.
    Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H
    J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
    Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
    Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone effect on tobacco withdrawal symptoms: a pilot study.
    Robinson MD; Smith WA; Cederstrom EA; Sutherland DE
    J Am Board Fam Pract; 1991; 4(2):89-94. PubMed ID: 2028830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
    Cinciripini PM; Lapitsky L; Seay S; Wallfisch A; Meyer WJ; van Vunakis H
    J Clin Psychopharmacol; 1995 Jun; 15(3):182-91. PubMed ID: 7635995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation.
    Hilleman DE; Mohiuddin SM; Delcore MG
    J Clin Pharmacol; 1994 Mar; 34(3):222-4. PubMed ID: 8021329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic.
    West R; Hajek P; McNeill A
    Psychopharmacology (Berl); 1991; 104(1):91-6. PubMed ID: 1882007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
    Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F
    Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.